デフォルト表紙
市場調査レポート
商品コード
1212518

グルコースモニタリングデバイスの世界市場

Glucose Monitoring Devices

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 268 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
グルコースモニタリングデバイスの世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 268 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

グルコースモニタリングデバイスの世界市場は2030年に192億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に131億米ドルと推定されるグルコースモニタリングデバイスの世界市場は、2030年までに192億米ドルの改定規模に達し、2022年から2030年にかけてCAGR 4.8%で成長すると予測されます。本レポートで分析したセグメントの一つであるセルフモニタリング機器は、CAGR4%を記録し、分析期間終了時には113億米ドルに達すると予測されます。パンデミック後の回復を考慮し、持続血液グルコースモニタリングデバイス分野の成長は、今後8年間のCAGRが6.2%に修正されました。

米国市場は36億米ドル、中国はCAGR8%で成長予測

米国のグルコースモニタリングデバイス市場は、2022年には36億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてCAGR8%で推移し、2030年には41億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ1.6%と5.3%の成長が予測されています。欧州では、ドイツがCAGR2.6%で成長すると予測されています。

調査対象企業の例

  • Abbott Diabetes Care, Inc.
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • Alive Technologies Pty. Ltd.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beurer GmbH
  • Dexcom, Inc.
  • GlySens Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Omron Healthcare Co., Ltd.
  • Roche Diagnostics
  • Senseonics Holdings, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • タッチTG
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-3420

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Glucose Monitoring Devices Market to Reach $19.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Glucose Monitoring Devices estimated at US$13.1 Billion in the year 2022, is projected to reach a revised size of US$19.2 Billion by 2030, growing at aCAGR of 4.8% over the period 2022-2030. Self-Monitoring Devices, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$11.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Continuous Blood Glucose Monitoring Devices segment is readjusted to a revised 6.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 8% CAGR

The Glucose Monitoring Devices market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.1 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 32 Featured):

  • Abbott Diabetes Care, Inc.
  • ACON Laboratories, Inc.
  • AgaMatrix, Inc.
  • Alive Technologies Pty. Ltd.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beurer GmbH
  • Dexcom, Inc.
  • GlySens Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nova Biomedical Corporation
  • Omron Healthcare Co., Ltd.
  • Roche Diagnostics
  • Senseonics Holdings, Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global Diabetes Epidemic
    • Growth Drivers in a Nutshell
    • Recent Market Activity
    • Glucose Monitoring Undergoes Notable Transformation over the Years: An Evolutionary Scan
    • Evolution of Diabetes Testing over the Years with Key Features in Each Period
    • Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market Growth
    • Diabetes: One of the Leading Causes of Death Globally
    • Diabetes Incidence and Prevalence by Region/Country
    • Global Market Outlook
    • Developed Countries are Dominant Markets, while Developing Countries Spearhead Market Growth
    • Glucose Monitoring Devices - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth
    • Select Disruptive Glucose Monitors Promising Reduced Pain, Lesser Data Load, and Zero Worries
    • Innovative Smart Glucometers for Sugar Monitoring
    • Need for Real-Time Glucose Sensing and Monitoring Drive Strong Demand for Minimally-Invasive CGM Devices
    • Myriad Benefits of CGMs
    • CGM Market Gradually Breaks through Barriers to Adoption
    • Intensive Care Units: A Highly Promising Market for CGMs
    • Key Challenges Hampering Widespread Adoption of CGM Systems
    • Despite Competition from CGM Systems, SGM Devices Continue to Dominate Sales
    • Blood Glucose Test Strips: The Largest Segment
    • Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring Systems
    • Self-Monitoring/Household Blood Glucose:Sustaining Growth in Demand
    • Key Trends in the Glucose Meter/Monitoring Systems
    • Smartphone Penetration Favors SMBG Market
    • Barriers to Adoption of New Technology in BGM Products
    • Accuracy Issues Plague Blood Glucose Meters Market
    • Advancements in Glucose Monitoring Devices Offers a New Ray of Hope
    • Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped Potential
    • Undiagnosed Diabetics: More Prone to Cardiovascular Diseases
    • Increased Vulnerability of Diabetics to Various Health Complications Drives the Need for Timely Glucose Monitoring
    • Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular Complications
    • Higher Risk of Diabetes in the Fast Expanding Aging Population Benefit Market Expansion
    • Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
    • Increasing Healthcare Expenditure Boosts Demand for SGM and CGM Devices
    • Increasing Obesity Levels Underpins Market Growth
    • K'Track: Discreet and Painless Glucose- Monitoring Wearable
    • The Sugar iQ App Provide Predictive Diabetes Care
    • DIABNEXT® CLIPSULIN®: World's First A.I Tool for Diabetes
    • e-mosquito CGM Device
    • FreeStyle Libre Flash Glucose Monitoring System
    • MyDario Mobile Data Management Platform
    • The New Handheld RL-BGM Device
  • TOUCH TG
    • Pocket-Sized Gadgets
    • Digital Contact Lenses
    • Gamification
    • Leveraging Big Data
    • Digital Tattoos
    • OneTouch® Verio Flex® Monitoring System
    • Artificial Pancreas System (APS): The Next Big Thing in Glucose Monitoring
    • The First-of-its-Kind Artificial Pancreas by Medtronic
    • Non-invasive, Acetone Detecting Breathalyzer for Glucose Testing
    • Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring
    • EMG 1000: Needle-free Device for Glucose Monitoring
    • Glucase: Smartphone Case with Glucose Testing Kit
    • Painless Diabetes Monitoring Using NFC Technology
    • GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels
    • ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes
    • NoStrip™ Technology: Eliminating Need for Individual Test Strips
    • Other Innovative and Advanced Glucose Monitoring Systems
    • Notable Early-stage Investigative Glucose Monitoring Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Self-Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Self-Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Self-Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Continuous Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Continuous Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Continuous Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 19: World Glucose Monitoring Devices Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 22: USA 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: USA 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: Canada 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: Canada 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • JAPAN
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Japan 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Japan 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • CHINA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: China 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: China 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • EUROPE
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Glucose Monitoring Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Europe 18-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Europe 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Europe 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • FRANCE
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: France 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: France 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • GERMANY
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Germany 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: Germany 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: Italy 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: Italy 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: UK 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: UK 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Spain 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Spain 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: Russia 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Russia 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Rest of Europe 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Glucose Monitoring Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 18-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Asia-Pacific 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • AUSTRALIA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: Australia 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 109: Australia 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • INDIA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 112: India 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 115: India 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 118: South Korea 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 121: South Korea 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • LATIN AMERICA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Glucose Monitoring Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 130: Latin America 18-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 133: Latin America 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 136: Latin America 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 139: Argentina 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 142: Argentina 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 145: Brazil 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 148: Brazil 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 151: Mexico 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 154: Mexico 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 157: Rest of Latin America 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 160: Rest of Latin America 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • MIDDLE EAST
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Glucose Monitoring Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 163: Middle East 18-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 166: Middle East 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 169: Middle East 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 172: Iran 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 175: Iran 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 178: Israel 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 181: Israel 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 184: Saudi Arabia 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 187: Saudi Arabia 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 190: UAE 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 193: UAE 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 196: Rest of Middle East 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 199: Rest of Middle East 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030
  • AFRICA
    • Glucose Monitoring Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Glucose Monitoring Devices by Product Type - Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 202: Africa 18-Year Perspective for Glucose Monitoring Devices by Product Type - Percentage Breakdown of Value Sales for Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices for the Years 2012, 2023 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Glucose Monitoring Devices by End-Use - Hospitals, Home Care and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 205: Africa 18-Year Perspective for Glucose Monitoring Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Diagnostic Centers for the Years 2012, 2023 & 2030

IV. COMPETITION